| 期 |
标题 |
文件 |
| 卷 13, 编号 4 (2011) |
17 noyabrya 2011 g. v ramkakh X Natsional'nogoonkologicheskogo kongressa sostoyalsyasimpozium «Biosimilyary: novye gorizontyrazvitiya zdravookhraneniya» |
|
|
- -.
|
| 卷 14, 编号 3 (2012) |
22 sentyabrya 2012 g. sostoyalsya press-brifing, posvyashchennyy roli targetnoy terapii v preodolenii lekarstvennoy rezistentnosti pri lechenii metastaticheskogo raka molochnoy zhelezy (mRMZh) i, v chastnosti, predstavleniyu obshchestvennosti novykh zaregistrirovannykh pokazaniy dlya primeneniya preparata Afinitor pri mRMZh |
|
|
- -.
|
| 卷 12, 编号 4 (2010) |
25 noyabrya 2010 g. «AstraZeneka Rossiya» ob\"yavilapromezhutochnye rezul'taty issledovaniya EPICLIN |
|
|
- -.
|
| 卷 14, 编号 3 (2012) |
6-9 sentyabrya 2012 g. v Marsele sostoyalsya 10-y kongress Evropeyskoy assotsiatsii po neyroonkologii (EANO) |
|
|
Absalyamova O.
|
| 卷 10, 编号 1 (2008) |
8 let nadezhdy: novye dannye issledovaniya ATAS |
|
|
- -.
|
| 卷 13, 编号 3 (2011) |
ASCO 2011: novye standartyv lechenii stromal'nykh opukholeyzheludochno-kishechnogo trakta |
|
|
Nikulin M.
|
| 卷 10, 编号 2 (2008) |
ASCO Innovatsionnye metody bor'by s onkologicheskimi zabolevaniyam |
|
|
- -.
|
| 卷 19, 编号 3 (2017) |
BCD-100 - first russian PD-1 inhibitor |
(Rus)
|
|
Tyulyandin S., Fedyanin M., Semiglazova T., Moiseenko V., Odintsova S., Alekseev B., Ivanov R., Shustova M.
|
| 卷 18, 编号 1 (2016) |
BRCA-associated ovarian cancer (the experience of the Chemotherapy Department in N.N.Blokhin Russian Cancer Research Center of the Ministry of Health of Russia) |
(Rus)
|
|
Khokhlova S., Gorbunova V., Lyubchenko L., Imyanitov E.
|
| 卷 24, 编号 3 (2022) |
CAR NK-сells for the treatment of hematological malignancies: A review |
(Rus)
|
|
Gribkova I.
|
| 卷 15, 编号 1 (2013) |
CUP-syndrome: the present view of the problem (a review of literature) |
|
|
Levitskaya N., Lewitzki V., Komarov I., Nemtsova M., Poddubnaya I.
|
| 卷 14, 编号 2 (2012) |
Cubpopulyatsionnyy sostav i tsitokinsekretornaya funktsiya kletok produkta separatsii u bol'nykh limfomami |
|
|
Baranova D., Sakhno L., Kryuchkova I., Pronkina N., Batorov E., Tikhonova M., Gilevich A., Sergeevicheva V., Sizikova S., Ushakova G., Ostanin A., Pospelova T., Chernykh E.
|
| 卷 17, 编号 4 (2015) |
FDA approves Opdivo to treat advanced form of kidney cancer |
|
|
- -.
|
| 卷 17, 编号 4 (2015) |
FDA approves ixazomib in combination with lenalidomide and dexamethasone for multiple myeloma |
|
|
- -.
|
| 卷 16, 编号 3 (2014) |
HER2-positive disseminated gastric and gastro-oesophageal junction adenocarcinoma: forecast, clinical course, treatment |
|
|
Besova N.
|
| 卷 11, 编号 2 (2009) |
HER-2-targetnaya terapiya raka molochnoy zhelezy: monoklonal'nye antitela i ingibitory tirozinkinazy |
|
|
Ognerubova I.
|
| 卷 14, 编号 1 (2012) |
HER2-testirovanie metodamiimmunogistokhimii, fluorestsentnoy(FISH) i khromogennoy (SISH) in situgibridizatsii pri rake zheludkai pishchevodno-zheludochnogo perekhoda |
|
|
Zavalishina L., Ryazantseva A., Andreeva Y., Frank G.
|
| 卷 24, 编号 1 (2022) |
NGAL and KIM-1 – early urinary biomarkers of nephrotoxicity mediated by cisplatin: Observational study |
(Rus)
|
|
Grechukhina K., Chebotareva N., Zhukova L., Dorofeev A., Krasnova T.
|
| 卷 19, 编号 2 (2017) |
PARP inhibitors in female reproductive system cancers |
(Rus)
|
|
Pokataev I., Tyulyandin S.
|
| 卷 22, 编号 2 (2020) |
SDH-deficient gastrointestinal stromal tumors: paradoxical effect of imatinib |
(Rus)
|
|
Filonenko D., Meshcheryakov A., Arkhiri P., Nikulin M., Kolobanova E.
|
| 卷 23, 编号 3 (2021) |
V-shaped radial forearm free flap is a new way to reduce the morbidity of the donor area |
(Rus)
|
|
Bolotin M., Mudunov A., Sobolevsky V., Akhundov A., Gelfand I., Sopromadze S.
|
| 卷 7, 编号 2 (2005) |
«Problema optimizatsii ad\"yuvantnoy endokrinnoy terapii na rannikh stadiyakh raka molochnoy zhelezy» |
|
|
Semiglazov V., Poddubnaya I.
|
| 卷 13, 编号 4 (2011) |
«Rosh» i «Farmstandart»:god strategicheskogo partnerstva |
|
|
- -.
|
| 卷 22, 编号 4 (2020) |
Avapritinib: a new tyrosine kinase inhibitor for treatment of advanced gastrointestinal stromal tumors. The literature review and clinical case |
(Rus)
|
|
Filonenko D., Medvedeva B., Meshcheryakov A.
|
| 卷 16, 编号 3 (2014) |
Avastin in clinical chemotherapy of malignant tumors |
|
|
Gorbunova V.
|
| 卷 17, 编号 3 (2015) |
Adenosquamous carcinoma of the colon: case report |
|
|
Nefedova N., Kharlova O., Malkov P., Kharlov N., Danilova N.
|
| 卷 22, 编号 2 (2020) |
Adjuvant targeted therapy for non-small cell lung cancer |
(Rus)
|
|
Laktionov K., Kazakov A., Gordiev M., Kononets P., Akhmedov B., Maevskaia J.
|
| 卷 11, 编号 4 (2009) |
Ad\"yuvantnaya terapiyav lechenii gastrointestinal'nykh stromal'nykh opukholey |
|
|
Nikulin M., Stilidi I.
|
| 卷 3, 编号 2 (2001) |
Ad\"yuvantnaya khimioterapiya raka molochnoy zhelezy: ot alkiliruyushchikh preparatov i antimetabolitov k antratsiklinam i taksonam |
|
|
Voznyy E.
|
| 卷 9, 编号 2 (2007) |
Ad\"yuvantnaya endokrinoterapiya postmenopauzal'nykh bol'nykh rakom molochnoy zhelezy |
|
|
Semiglazov V., Semiglazov V.
|
| 卷 10, 编号 1 (2008) |
Ad\"yuvantnoe lechenie raka tolstoy kishki |
|
|
Artamonova E., Podregul'skiy K.
|
| 卷 23, 编号 2 (2021) |
Acalabrutinib in the treatment of chronic lymphocytic leukemia: a review of recent evidence |
(Rus)
|
|
Petrenko A., Kislova M., Dmitrieva E., Nikitin E.
|
| 卷 3, 编号 4 (2001) |
Aktivatory plazminogena urokinaznogo i tkanevogo tipov i ikh ingibitor pervogo tipa pri rake pishchevoda (predvaritel'nye rezul'taty) |
|
|
Gershteyn E., Goncharov D., Kushlinekiy N., Poddubnaya I.
|
| 卷 23, 编号 4 (2021) |
Activation of the PI3K-AKT-mTOR cascade in uterine leiomyosarcoma: a retrospective study of 31 patients |
(Rus)
|
|
Rozonova O., Artamonova E., Kozlov N., Delektorskaya V., Egorova A., Stilidi I.
|
| 卷 12, 编号 4 (2010) |
Aktivnaya khirurgicheskaya taktikav sovremennom algoritme lecheniyarasprostranennogo raka yaichnika |
|
|
Pokataev I., Stenina M., Tyulyandina A., Tyulyandin S.
|
| 卷 2, 编号 1 (2000) |
Aktual'nye voprosy limfodissektsii u bol'nykh rakom grudnogo otdela pishchevoda |
|
|
Davydov M., Stilidi I., Arzykulov D., Ter-Ovanesov M., Godzhamanov Y., Lagoshnyy A.
|
| 卷 23, 编号 1 (2021) |
Actual treatment options for locally advanced and metastatic cutaneous squamous cell carcinoma |
(Rus)
|
|
Ignatova A.
|
| 卷 16, 编号 2 (2014) |
Algorithm of treatment of patients with castrate-resistant prostate cancer: modern concept and perspectives |
|
|
Alekseev B., Nyushko K., Kalpinskiy A., Kaprin A.
|
| 卷 12, 编号 1 (2010) |
Alimta (pemetreksed) v pervoylinii lecheniya disseminirovannogonemelkokletochnogo raka legkogo |
|
|
Bychkov M., Bol'shakova S., Bychkov Y.
|
| 卷 13, 编号 3 (2011) |
Allel'nye varianty v genakh BRCA1,BRCA2, TP53, assotsiirovannyes razvitiem raka molochnoy zhelezy |
|
|
Sytenkova K., Guzieva Z., Kazakov M., Lyubchenko L., Poddubnaya I.
|
| 卷 19, 编号 1 (2017) |
Albumin-bound paclitaxel in the treatment of metastatic breast cancer |
(Rus)
|
|
Artamonova E.
|
| 卷 23, 编号 4 (2021) |
Alternative agents to prophylactic platelet transfusion for preventing bleeding in people with thrombocytopenia due to chronic bone marrow failure: a meta-analysis and systematic review (Russian Translation of Cochrane Plain Language Summary) |
(Rus)
|
|
Gainudinova D.
|
| 卷 9, 编号 2 (2007) |
Ambulatornoe lechenie khronicheskogo limfoleykoza: doma i steny pomogayut v ramkakh mezhdunarodnogo meditsinskogo simpoziuma «Rekomenduy svobodu!» |
|
|
- -.
|
| 卷 12, 编号 4 (2010) |
Analiz bazovykh issledovaniy III fazy podtverzhdaetpreimushchestvo denosumaba pered standartnoy terapieyu bol'nykh s metastaticheskim porazheniem kostey |
|
|
- -.
|
| 卷 24, 编号 3 (2022) |
The analysis of the relationship between transferrin receptor 1 (TfR1) and clinical, morphological and immunophenotypic characteristics of breast cancer: retrospective cohort study |
(Rus)
|
|
Chulkova S., Sholokhova E., Poddubnaya I., Stilidi I., Tupitsyn N.
|
| 卷 13, 编号 3 (2011) |
Analiz zabolevaemosti rakommolochnoy zhelezy s uchetom statusa HER2na territorii Rossiyskoy Federatsii |
|
|
Ryazhenov V., Gorokhova S.
|
| 卷 6, 编号 4 (2004) |
Analiz lecheniya onkoginekologicheskikh opukholey v Yakutii |
|
|
Kipriyanova N., Afanas'eva L., Aksel' E., Poddubnaya I.
|
| 卷 24, 编号 3 (2022) |
Analysis of the complications of endocrine therapy with tamoxifen in breast cancer: clinical and pharmacogenetic aspects. Prospective pharmacogenetic cohort study |
(Rus)
|
|
Savelyeva M., Golubenko E., Sozaeva Z., Poddubnaya I., Korennaya V.
|
| 卷 7, 编号 1 (2005) |
Analiz rezul'tatov vnedreniya Regional'noy rossiyskoy programmy lecheniya pervichno-generalizovannogo i metastaticheskogo raka molochnoy zhelezy v Voronezhskom oblastnom klinicheskom onkologicheskom dispansere |
|
|
Chevardov N., Tolstykh L., Puzakov K., Potapov Y.
|
| 卷 8, 编号 3 (2006) |
Analiz sostoyaniya onkoginekologicheskoy pomoshchi v navoiyskom regione (Respublika Uzbekistan) |
|
|
Kudryavtsev I., Kerimov R.
|
| 卷 5, 编号 3 (2003) |
Analiz sostoyaniya onkoginekologicheskoy pomoshchi naseleniyu v Respublike Sakha (Yakutiya) |
|
|
Aksel' E., Afanas'eva L., Kipriyanova N., Smetanina V., Poddubnaya I.
|
| 卷 5, 编号 3 (2003) |
Analiz sostoyaniya onkologicheskoy pomoshchi v Respublike Sakha (Yakutiya) za 1991-2001 gg |
|
|
Poddubnaya I., Aksel' E., Kipriyanova N.
|
| 卷 23, 编号 1 (2021) |
Analysis of the efficacy and safety of eribulin therapy in patients with HR+/HER2- metastatic breast cancer pretreated with CDK4/6 inhibitors in real Russian practice |
(Rus)
(Eng)
|
|
Kolyadina I., Abidova N., Akopyan A., Antonova G., Arapova O., Bobrova E., Bolotina L., Valiakhmetova C., Vasilevskaya A., Vladimirova L., Volkonskiy M., Ganshina I., Gudkova I., Dergunov A., Evstigneeva I., Egurenkova V., Emshanov A., Zhukova L., Zueva E., Karabina E., Kolokolov J., Kuzmicheva S., Kuchevskaya O., Luev I., Maistrenko K., Markizova E., Marfutov V., Medvedev S., Merzlikina Y., Nersesova T., Ovchinnikova E., Orlova S., Samaneva N., Stativko O., Storozhakova A., Stroyakovskiy D., Sultanbaev A., Tekeeva A., Fadeeva N., Fedorova A., Shalaeva O., Shangina I., Shirokova O., Shumskikh A., Yakubova M.
|
| 卷 10, 编号 2 (2008) |
ANAPLASTIChESKAYa KRUPNOKLETOChNAYa LIMFOMA VZROSLYKh:VLIYaNIE PROGNOSTIChESKIKh FAKTOROV NA TERAPIYu |
|
|
Semenova A., Sorokin E., Poddubnaya I., Probatova N., Timofeeva O.
|
| 卷 4, 编号 1 (2002) |
Anastrozol kak perspektiva ad\"yuvantnogo lecheniya raka molochnoy zhelezy u bol'nykh v menopauze |
|
|
Gorbunova V.
|
| 卷 16, 编号 2 (2014) |
Angiogenesis as a target for cancer therapy |
|
|
Imyanitov E.
|
| 卷 14, 编号 1 (2012) |
Anemiya v onkologii:podkhody k lecheniyu |
|
|
Ptushkin V.
|
| 卷 24, 编号 4 (2022) |
Anemia and iron deficiency in cancer patients: the role of intravenous iron supplements (a literature review) |
(Rus)
|
|
Sakaeva D.
|
| 卷 12, 编号 3 (2010) |
Anemiya i sposoby ee korrektsiiu onkologicheskikh bol'nykh |
|
|
Babicheva L., Poddubnaya I.
|
| 卷 4, 编号 3 (2002) |
Anemiya pri zlokachestvennykh opukholyakh |
|
|
Breder V., Gorbunova V., Besova N.
|
| 卷 13, 编号 2 (2011) |
Anemiya pri zlokachestvennykhnovoobrazovaniyakh: printsipy terapii |
|
|
Gorokhovskaya G., Petina M.
|
| 卷 14, 编号 2 (2012) |
Antiangiogennaya terapiya v lechenii glioblastomy: obzor i sobstvennye klinicheskie dannye |
|
|
Kobyakov G., Absalyamova O., Urakov S., Smolin A., Strazhev S.
|
| 卷 15, 编号 3 (2013) |
Antiangiogennaya terapiya disseminirovannogo kolorektal'nogo raka |
|
|
Meshcheryakov A.
|
| 卷 23, 编号 1 (2021) |
Antiangiogenic therapy for breast cancer with triple negative phenotype |
(Rus)
|
|
Ganshina I., Ivanova K., Gordeeva O., Arkhipov A., Zhukova L.
|
| 卷 23, 编号 3 (2021) |
Antiangiogenic therapy in pretreated patients with lung adenocarcinoma without activating mutations: new features |
(Rus)
|
|
Reutova E., Laktionov K.
|
| 卷 13, 编号 4 (2011) |
Antiangiogennaya terapiyapri rake molochnoy zhelezys troynym negativnym fenotipom |
|
|
Zhukova L.
|
| 卷 2, 编号 1 (2000) |
Antiemetogennaya terapiya ondasetronom pri polikhimioterapii zlokachestvennykh opukholey u devochek |
|
|
Safonova S., Punanov Y., Kolygin B.
|
| 卷 9, 编号 1 (2007) |
Antiestrogennaya terapiya pri rake molochnoy zhelezy. Naskol'ko bezopasny ingibitory aromatazy? |
|
|
Ptushkin V.
|
| 卷 2, 编号 1 (2000) |
Arimideks - novyy nesteroidnyy selektivnyy ingibitor aromatazy Predvaritel'nye rezul'taty "Otkrytogo nesravnitel'nogo issledovaniya po otsenke effektivnosti i perenosimosti arimideksa ( 1 mg) pri lechenii rasprostranennogo raka molochnoy zhelezy u zhenshchin |
|
|
Gorbunova V., Gorin A., Odintsov S., Kozlov D., Vychkov M., Dobrovol'skaya N., Vazin I., Meshcheryakov A.
|
| 卷 5, 编号 4 (2003) |
Arimideks (anastrozol) v sravnenii s tamoksifenom v neoad\"yuvantnoy endokrinoterapii bol'nykh rakom molochnoy zhelezy |
|
|
Semiglazov V., Zhil'tsova E., Semiglazov V., Ivanov V., Dashyan G., Klettsel' A., Bozhok A., Nurgaziev K., Topuzov E., Krivorot'ko P., Tsyrlina E., Bershteyn L.
|
| 卷 3, 编号 4 (2001) |
Arimideks: novye vozmozhnosti v lechenii generalizovannogo raka molochnoy zhelezy |
|
|
Borisov V.
|
| 卷 11, 编号 4 (2009) |
Aromazin v ad\"yuvantnoy terapii raka molochnoy zhelezy |
|
|
Artamonova E.
|
| 卷 7, 编号 2 (2005) |
Aromazin (ekzemestan) v neoad\"yuvantnoy i ad\"yuvantnoy gormonoterapii raka molochnoy zhelezy |
|
|
Makarenko N.
|
| 卷 7, 编号 3 (2005) |
Aromazin: printsip deystviya |
|
|
Imyanitov E.
|
| 卷 12, 编号 3 (2010) |
Astenicheskie rasstroystva,assotsiirovannye s khimioterapieyzlokachestvennykh novoobrazovaniy(Obzor literatury) |
|
|
Shafigullin M., Ivanov S., Gorbunova V., Meshcheryakov A.
|
| 卷 7, 编号 2 (2005) |
Astrotsitomy nizkoy stepeni zlokachestvennosti polushariy bol'shogo mozga |
|
|
Aleshin V., Karakhan V.
|
| 卷 24, 编号 1 (2022) |
Atezolizumab in the first-line treatment of metastatic non-small cell lung cancer. Clinical experience of the drug application. Case report |
(Rus)
|
|
Ognerubov N., Antipova T.
|
| 卷 17, 编号 3 (2015) |
Atsellbiya® - opyt primeneniya pervogo bioanaloga rituksimaba v rutinnoy praktike klinitsista |
|
|
- -.
|
| 卷 11, 编号 1 (2009) |
Bevatsizumab (Avastin) v kombinatsii s taksanami v 1-y linii lecheniya HER-2-negativnogo metastaticheskogo raka molochnoy zhelezy(Rezul'taty issledovaniya AVADO) |
|
|
Zhukova L.
|
| 卷 15, 编号 3 (2013) |
Bevatsizumab v kombinatsii s khimioluchevoy terapiey u bol'nykh glioblastomoy |
|
|
Smolin A., Konev A., Kobyakov G., Nikolaeva S., Shamanskaya Y., Gorbunov A.
|
| 卷 15, 编号 3 (2013) |
Bevatsizumab v kombinatsii s khimioterapiey pri rake molochnoy zhelezy |
|
|
Manzyuk L., Kovalenko E., Artamonova E., Osmanova L.
|
| 卷 12, 编号 3 (2010) |
Bevatsizumab v lechenii HER2-negativnogometastaticheskogo raka molochnoy zhelezy:sovremennye dannye ob effektivnostii bezopasnosti |
|
|
Zhukova L.
|
| 卷 12, 编号 1 (2010) |
Bevatsizumab pri metastaticheskomi retsidiviruyushchem rake molochnoy zhelezy:metaanaliz randomizirovannykh issledovaniy |
|
|
Kolyadina I., Poddubnaya I.
|
| 卷 16, 编号 3 (2014) |
Bevacizumab in advanced ovarian cancer: when, what for and why? |
|
|
Tjulandina A.
|
| 卷 25, 编号 2 (2023) |
Safety and toxicity of cabozantinib monotherapy in patients with advanced renal cell carcinoma: a Russian multicenter observational study |
(Rus)
|
|
Volkova M., Kalpinskiy A., Menshikov K., Gorbuleva L., Sultanbaev A., Evsyukova O., Meltonian V., Mishugin S., Maturov M., Olshanskaya A., Shemetov D., Sannikova T., Makhnutina M., Filipieva M., Gaijsina E., Ovchinnikova E., Mailian O., Alekseev B., Matveev V.
|
| 卷 26, 编号 1 (2024) |
Safety and efficacy of ribociclib in combination with letrozole in an extended population of patients with HR+/HER2- advanced breast cancer: analysis of data from a subgroup of patients from Russia in the phase lllb CompLEEment-1 study |
(Rus)
|
|
Zhukova L., Bolotina L., Dvornichenko V., Fadeeva N., Ganshina I., Grechukhina K., Hasanova A., Kislov N., Kudryavtsev I., Manikhas A., Musaeva N., Nizhegorodtseva A., Sadikova O., Sakaeva D., Snegovoy A., Stroyakovskiy D., Tjulandin S., Trishkina E., Vladimirova L., Volkov N., Kostalanova Y.
|
| 卷 12, 编号 3 (2010) |
Bezopasnost' ibandronovoy kislotypri dlitel'nom primenenii |
|
|
Semenov N.
|
| 卷 24, 编号 2 (2022) |
Are oral blood thinners safe and effective for people being treated for cancer? |
(Rus)
|
|
Ziganshin A.
|
| 卷 14, 编号 2 (2012) |
Bendamustin v terapii nekhodzhkinskikh limfom |
|
|
Semenova A.
|
| 卷 24, 编号 1 (2022) |
The biobank of the National Medical Research Centre for Oncology as a resource for research in the field of personalized medicine: A review |
(Rus)
|
|
Kit O., Timofeeva S., Sitkovskaya A., Novikova I., Kolesnikov E.
|
| 卷 22, 编号 2 (2020) |
Biobanks in oncology: global experience and Russian reality |
(Rus)
|
|
Kaprin A., Ivanov S., Petrov V., Dukhova N., Dvinskikh N., Falaleeva N., Grivtsova L.
|
| 卷 23, 编号 2 (2021) |
Biological features of ductal carcinoma in situ: clinical role and basis for treatment individualization |
(Rus)
|
|
Kolyadina I., Butrimova A., Poddubnaya I., Kоmetova V., Rodionov V.
|
| 卷 7, 编号 2 (2005) |
Biologicheskie kharakteristiki opukholi (proliferativnaya aktivnost', ploidnost' i steroidnye retseptory) i ikh vliyanie na neposredstvennye i otdalennye rezul'taty lecheniya zapushchennogo raka molochnoy zhelezy |
|
|
Nikolaeva T., Vyshinskaya G., Rotobel'skaya L.
|
| 卷 16, 编号 4 (2014) |
Tumor biology or adjuvant systemic therapy: what determines the risk of recurrence in breast cancer stage I? |
|
|
Kolyadina I., Poddubnaya I., Trofimova O., Frank G., Karseladze A., Komov D.
|
| 卷 13, 编号 4 (2011) |
Biosimilyary: novye vozmozhnostisovremennoy lekarstvennoy terapiiopukholey |
|
|
Poddubnaya I.
|
| 卷 10, 编号 3 (2008) |
Bondronat v forme dlya priema vnutr' effektiven u bol'nykh s kostnymi metastazami raka molochnoy zhelezy. Opyt odnogo tsentra |
|
|
Semenov N., Lichinitser M., Vyshinskaya G., Meshcheryakov A., Novikov V., Gutorov S., Borisova E., Nakhalova T., Mikhina Z., Lyubimova N., Chaklina E., Aplevich N.
|
| 卷 19, 编号 2 (2017) |
Brachytherapy with ultrasound assistance in patients with cervical cancer |
(Rus)
|
|
Kizhaev Y., Razumova E., Bessolova O.
|
| 卷 18, 编号 2 (2016) |
Brentuximab vedotin in the treatment of relapsed and refractory forms of Hodgkin lymphoma |
(Rus)
|
|
Demina E.
|
| 卷 2, 编号 3 (2000) |
Bronkhoskopiya v diagnostike i lechenii opukholey trakheobronkhial'nogo stvola |
|
|
Poddubnyy B., Ungiadze G., Belousova N., Polotskiy B., Kontsevaya A., Alekseeva T., Kondrat'eva T.
|
| 卷 14, 编号 2 (2012) |
V Moskve sostoyalos' obsuzhdenie proekta Rossiyskikh klinicheskikh rekomendatsiy po diagnostike i lecheniyu zlokachestvennykh limfoproliferativnykh zabolevaniy, osnovannykh na printsipakh dokazatel'noy meditsiny i mnenii ekspertov |
|
|
- -.
|
| 1 - 100 的 1319 信息 |
1 2 3 4 5 6 7 8 9 10 11 12 13 14 > >> |
